ERBB2 and breast cancer: A multiplexed branched-DNA assay revealed that HER2 gene expression is increased in benign and malignant canine mammary tumors compared with normal healthy mammary glands [38], and HER2, HER3, and HER4 are amplified in canine mammary tumor cell lines [39].